The importance of patient-reported outcomes: A call for their comprehensive integration in cardiovascular clinical trials

European Heart Journal

Volumn 35, Issue 30, 2014, Pages 2001-2009

  Anker, Stefan D ^a,b   Agewall, Stefan ^c   Borggrefe, Martin ^d,e   Calvert, Melanie ^f   Caro, J Jaime ^g   Cowie, Martin R ^h   Ford, Ian ⁱ   Paty, Jean A ^j   Riley, Jillian P ^k   Swedberg, Karl ^h,l   Tavazzi, Luigi ^m   Wiklund, Ingela ⁿ   Kirchhof, Paulus ^o  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g MCGILL UNIVERSITY   (Canada)

^h NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j Invivodata Inc   (United States)

^k ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^l UNIVERSITY OF GOTHENBURG   (Sweden)

^m MARIA CECILIA HOSPITAL   (Italy)

ⁿ UNITED BIOSOURCE CORPORATION   (United States)

^o SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

more..

Author keywords

Cardiovascular clinical trials; Health related quality of life; Patient reported outcomes

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; MEDICAL SOCIETY; MORBIDITY; NOMENCLATURE; PATIENT CARE; PATIENT INFORMATION; PATIENT REPORTED OUTCOME; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; STANDARD; SURVIVAL; SYMPTOM; WELLBEING; CARDIOLOGY; CARDIOVASCULAR DISEASES; EUROPE; INFORMATION DISSEMINATION; OUTCOME ASSESSMENT; POLICY; PROCEDURES; STATISTICAL ANALYSIS;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EUROPE; HUMANS; INFORMATION DISSEMINATION; INSURANCE, HEALTH, REIMBURSEMENT; ORGANIZATIONAL POLICY; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC;

EID: 84906654366     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu205     Document Type: Review

References (51)

1. US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. http://www.fda.gov/down loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM193282.pdf. 2009.
2. Rahimi K, Malhotra A, Banning AP, Jenkinson C. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ 2010;341:c5707.
3. Gnanasakthy A, Mordin M, Clark M, DeMuro C, Fehnel S, Copley-Merriman C. A review of patient-reported outcome labels in the United States: 2006 to 2010. Value Health 2012;15:437-442.
4. Grady KL, Warner SL, Pagani FD, Teuteberg J, Pamboukian SV, Birks E, Moore S, Kirklin JK. Beyond survival: Recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support. J Heart Lung Transplant 2012;31:1158-1164.
5. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59-65.
6. McKenna SP. Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med 2011;9:86.
7. Valderas JM, Alonso J. Patient reported outcome measures: a model-based classification system for research and clinical practice. Qual Life Res 2008;17:1125-1135.
8. Burke LB, Kennedy DL, Miskala PH, Papadopoulos EJ, Trentacosti AM. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther 2008;84:281-283.
9. Baldwin M, Spong A, Doward L, Gnanasakthy A. Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond. Patient 2011;4:11-17.
10. Doward LC, Gnanasakthy A, Baker MG. Patient reported outcomes: looking beyond the label claim. Health Qual Life Outcomes 2010;8:89.
11. Calvert MJ, Freemantle N. Use of health-related quality of life in prescribing research. Part 1: why evaluate health-related quality of life? J Clin Pharm Ther 2003;28:513-521.
12. Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res 2009;18:99-107.
13. Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency. Reflection paper on the regulatory guidance for the use of health-related quality of life measures in the evaluation of medicinal products. http://www ema europa eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/ WC500003637 pdf. 2005.
14. Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E, Reeve BB, Wu AW. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care 2012;50:1060-1070.
15. Fairclough DL. Patient reported outcomes as endpoints in medical research. Stat Methods Med Res 2004;13:115-138.
16. Tengs TO, Yu M, Luistro E. Health-related quality of life after strokea comprehensive review. Stroke 2001;32:964-972.
17. Snyder CF, Jensen R, Courtin SO, Wu AW. PatientViewpoint: a website for patientreported outcomes assessment. Qual Life Res 2009;18:793-800.
18. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 2008;11:322-333.
19. Rose M, Bezjak A. Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples. Qual Life Res 2009;18:125-136.
20. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, DeWalt D, Fries JF, Gershon R, Hahn EA, Lai JS, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010;63:1179-1194.
21. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10(Suppl. 2):S125-S137.
22. Fielding S, Maclennan G, Cook JA, Ramsay CR. A review of RCT s in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Trials 2008;9:51.
23. Curran D, Molenberghs G, Fayers PM, Machin D. Incomplete quality of life data in randomized trials: missing forms. Stat Med 1998;17:697-709.
24. Wiklund I, Swedberg K. Some methodological problems in analyzing quality of life data in severe congestive heart failure patients. J Clin Res Pharmacoepidemiol 1991; 5:265-273.
25. Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013;381:29-39.
26. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77: 371-383.
27. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102-109.
28. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006;4:70.
29. Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC. Interpreting and reporting results based on patient-reported outcomes. Value Health 2007; 10(Suppl. 2):S116-S124.
30. Brundage M, Feldman-Stewart D, Leis A, Bezjak A, Degner L, Velji K, Zetes-Zanatta L, Tu D, Ritvo P, Pater J. Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol 2005;23: 6949-6956.
31. Guyatt G, Schunemann H.Howcan quality of life researchers make their work more useful to health workers and their patients? Qual Life Res 2007;16:1097-1105.
32. Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 2013;309:814-822.
33. Brouwers C, Denollet J, de JN, Caliskan K, Kealy J, Pedersen SS. Patient-reported outcomes in left ventricular assist device therapy: a systematic reviewand recommendations for clinical research and practice. Circ Heart Fail 2011;4:714-723.
34. Eshelman AK, Mason S, Nemeh H, Williams C. LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant. Heart Fail Rev 2009;14:21-28.
35. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005;149: 664-669.
36. Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol 2011;4:242-250.
37. Pedersen SS, Versteeg H, Denollet J, Cheng JM, Serruys PW, van Domburg RT. Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stenting. Qual Life Res 2011;20:559-567.
38. Pedersen SS, Lambiase P, Boersma LV, Murgatroyd F, Johansen JB, Reeve H, Stuart AG, Adragao P, Theuns DA. Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry. Pacing Clin Electrophysiol 2012;35:574-579.
39. Hofer S, Saleem A, Stone J, Thomas R, Tulloch H, Oldridge N. The MacNew Heart Disease Health-Related Quality of Life Questionnaire in patients with angina and patients with ischemic heart failure. Value Health 2012;15:143-150.
40. Johnson MJ, Oxberry SG, Cleland JG, Clark AL. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. Eur J Heart Fail 2010;12:137-147.
41. Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED. Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J 2011;162:606-612.
42. Coyne K, Margolis MK, Grandy S, Zimetbaum P. The state of patient-reported outcomes in atrial fibrillation: a review of current measures. Pharmacoeconomics 2005; 23:687-708.
43. Salter KL, Moses MB, Foley NC, Teasell RW. Health-related quality of life after stroke: what are we measuring? Int J Rehabil Res 2008;31:111-117.
44. Doyle PJ. Measuring health outcomes in stroke survivors. Arch PhysMedRehabil 2002; 83:S39-S43.
45. Thompson DR, Yu CM. Quality of life in patients with coronary heart disease-I: assessment tools. Health Qual Life Outcomes 2003;1:42.
46. Thompson DR, Roebuck A. The measurement of health-related quality of life in patients with coronary heart disease. J Cardiovasc Nurs 2001;16:28-33.
47. Garin O, Ferrer M, Pont A, Rue M, Kotzeva A, Wiklund I, Van GE, Alonso J. Diseasespecific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res 2009;18:71-85.
48. Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Pina IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 2013;15:1082-1094.
49. Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis 1987;40:1129-1133.
50. Grant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J, Dargie H. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest 1999;116:1208-1217.
51. Peacock W, Mebazaa A. Clevidipine improves dyspnea in emergency department acute heart failure: a randomized, open-label study (abstract 15606). Circulation 2012;126:A15606.